Cargando…
A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain
Most patients who present with cancer have advanced disease and often suffer moderate to severe pain. Opioid therapy can be safe and effective for use in cancer patients with pain, but there are rightful concerns about inappropriate opioid use even in the cancer population. Since cancer patients liv...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771925/ https://www.ncbi.nlm.nih.gov/pubmed/26973529 http://dx.doi.org/10.3389/fphar.2016.00042 |
_version_ | 1782418471434321920 |
---|---|
author | Pergolizzi, Joseph V. Zampogna, Gianpietro Taylor, Robert Gonima, Edmundo Posada, Jose Raffa, Robert B. |
author_facet | Pergolizzi, Joseph V. Zampogna, Gianpietro Taylor, Robert Gonima, Edmundo Posada, Jose Raffa, Robert B. |
author_sort | Pergolizzi, Joseph V. |
collection | PubMed |
description | Most patients who present with cancer have advanced disease and often suffer moderate to severe pain. Opioid therapy can be safe and effective for use in cancer patients with pain, but there are rightful concerns about inappropriate opioid use even in the cancer population. Since cancer patients live longer than ever before in history (and survivors may have long exposure times to opioid therapy), opioid misuse among cancer patients is an important topic worthy of deeper investigation. Cancer patients with pain must be evaluated for risk factors for potential opioid misuse and aberrant drug-taking behaviors assessed. A variety of validated screening tools should be used. Of particular importance is the fact that pain in cancer patients changes frequently, whether it is related to their underlying disease (progression or remission), pain related to treatment (such as painful chemotherapy-induced peripheral neuropathy), and concomitant pain unrelated to cancer (such as osteoarthritis, headache, or back pain). Fortunately, clinicians can use universal precautions to help reduce the risk of opioid misuse while still assuring that cancer patients get the pain therapy they need. Another important new “tool” in this regard is the emergence of abuse-deterrent opioid formulations. |
format | Online Article Text |
id | pubmed-4771925 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-47719252016-03-11 A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain Pergolizzi, Joseph V. Zampogna, Gianpietro Taylor, Robert Gonima, Edmundo Posada, Jose Raffa, Robert B. Front Pharmacol Pharmacology Most patients who present with cancer have advanced disease and often suffer moderate to severe pain. Opioid therapy can be safe and effective for use in cancer patients with pain, but there are rightful concerns about inappropriate opioid use even in the cancer population. Since cancer patients live longer than ever before in history (and survivors may have long exposure times to opioid therapy), opioid misuse among cancer patients is an important topic worthy of deeper investigation. Cancer patients with pain must be evaluated for risk factors for potential opioid misuse and aberrant drug-taking behaviors assessed. A variety of validated screening tools should be used. Of particular importance is the fact that pain in cancer patients changes frequently, whether it is related to their underlying disease (progression or remission), pain related to treatment (such as painful chemotherapy-induced peripheral neuropathy), and concomitant pain unrelated to cancer (such as osteoarthritis, headache, or back pain). Fortunately, clinicians can use universal precautions to help reduce the risk of opioid misuse while still assuring that cancer patients get the pain therapy they need. Another important new “tool” in this regard is the emergence of abuse-deterrent opioid formulations. Frontiers Media S.A. 2016-03-01 /pmc/articles/PMC4771925/ /pubmed/26973529 http://dx.doi.org/10.3389/fphar.2016.00042 Text en Copyright © 2016 Pergolizzi, Zampogna, Taylor, Gonima, Posada and Raffa. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Pergolizzi, Joseph V. Zampogna, Gianpietro Taylor, Robert Gonima, Edmundo Posada, Jose Raffa, Robert B. A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain |
title | A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain |
title_full | A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain |
title_fullStr | A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain |
title_full_unstemmed | A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain |
title_short | A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain |
title_sort | guide for pain management in low and middle income communities. managing the risk of opioid abuse in patients with cancer pain |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771925/ https://www.ncbi.nlm.nih.gov/pubmed/26973529 http://dx.doi.org/10.3389/fphar.2016.00042 |
work_keys_str_mv | AT pergolizzijosephv aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain AT zampognagianpietro aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain AT taylorrobert aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain AT gonimaedmundo aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain AT posadajose aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain AT raffarobertb aguideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain AT pergolizzijosephv guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain AT zampognagianpietro guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain AT taylorrobert guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain AT gonimaedmundo guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain AT posadajose guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain AT raffarobertb guideforpainmanagementinlowandmiddleincomecommunitiesmanagingtheriskofopioidabuseinpatientswithcancerpain |